174 related articles for article (PubMed ID: 26457537)
21. Effect of the diamine nonleaving group in platinum-acridinylthiourea conjugates on DNA damage and cytotoxicity.
Guddneppanavar R; Choudhury JR; Kheradi AR; Steen BD; Saluta G; Kucera GL; Day CS; Bierbach U
J Med Chem; 2007 May; 50(9):2259-63. PubMed ID: 17408248
[TBL] [Abstract][Full Text] [Related]
22. Processing of anthracycline-DNA adducts via DNA replication and interstrand crosslink repair pathways.
Bilardi RA; Kimura KI; Phillips DR; Cutts SM
Biochem Pharmacol; 2012 May; 83(9):1241-50. PubMed ID: 22326903
[TBL] [Abstract][Full Text] [Related]
23. One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): determination of platinum-DNA adducts in cells treated with platinum(II) complexes.
Yamada K; Kato N; Takagi A; Koi M; Hemmi H
Anal Bioanal Chem; 2005 Aug; 382(7):1702-7. PubMed ID: 15959768
[TBL] [Abstract][Full Text] [Related]
24. In vitro studies on the mechanisms of oxaliplatin resistance.
Hector S; Bolanowska-Higdon W; Zdanowicz J; Hitt S; Pendyala L
Cancer Chemother Pharmacol; 2001 Nov; 48(5):398-406. PubMed ID: 11761458
[TBL] [Abstract][Full Text] [Related]
25. Adenine-N3 in the DNA minor groove - an emerging target for platinum containing anticancer pharmacophores.
Guddneppanavar R; Bierbach U
Anticancer Agents Med Chem; 2007 Jan; 7(1):125-38. PubMed ID: 17266509
[TBL] [Abstract][Full Text] [Related]
26. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts.
Chaney SG; Campbell SL; Bassett E; Wu Y
Crit Rev Oncol Hematol; 2005 Jan; 53(1):3-11. PubMed ID: 15607931
[TBL] [Abstract][Full Text] [Related]
27. DNA repair in response to anthracycline-DNA adducts: a role for both homologous recombination and nucleotide excision repair.
Spencer DM; Bilardi RA; Koch TH; Post GC; Nafie JW; Kimura K; Cutts SM; Phillips DR
Mutat Res; 2008 Feb; 638(1-2):110-21. PubMed ID: 17961607
[TBL] [Abstract][Full Text] [Related]
28. pH and thermo dual stimulus-responsive liposome nanoparticles for targeted delivery of platinum-acridine hybrid agent.
Zhou Q; You C; Ling Y; Wu H; Sun B
Life Sci; 2019 Jan; 217():41-48. PubMed ID: 30476500
[TBL] [Abstract][Full Text] [Related]
29. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines.
Mamenta EL; Poma EE; Kaufmann WK; Delmastro DA; Grady HL; Chaney SG
Cancer Res; 1994 Jul; 54(13):3500-5. PubMed ID: 8012973
[TBL] [Abstract][Full Text] [Related]
30. Nucleotide excision repair from site-specifically platinum-modified nucleosomes.
Wang D; Hara R; Singh G; Sancar A; Lippard SJ
Biochemistry; 2003 Jun; 42(22):6747-53. PubMed ID: 12779329
[TBL] [Abstract][Full Text] [Related]
31. Probing platinum-adenine-n3 adduct formation with DNA minor-groove binding agents.
Rao L; West TK; Saluta G; Kucera GL; Bierbach U
Chem Res Toxicol; 2010 Jul; 23(7):1148-50. PubMed ID: 20578739
[TBL] [Abstract][Full Text] [Related]
32. Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts.
Reardon JT; Vaisman A; Chaney SG; Sancar A
Cancer Res; 1999 Aug; 59(16):3968-71. PubMed ID: 10463593
[TBL] [Abstract][Full Text] [Related]
33. Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death.
Swift LP; Rephaeli A; Nudelman A; Phillips DR; Cutts SM
Cancer Res; 2006 May; 66(9):4863-71. PubMed ID: 16651442
[TBL] [Abstract][Full Text] [Related]
34. Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells.
Chijiwa S; Masutani C; Hanaoka F; Iwai S; Kuraoka I
Carcinogenesis; 2010 Mar; 31(3):388-93. PubMed ID: 20015866
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxicity and DNA binding mode of new platinum-iminoether derivatives with different configuration at the iminoether ligands.
Boccarelli A; Coluccia M; Intini FP; Natile G; Locker D; Leng M
Anticancer Drug Des; 1999 Jun; 14(3):253-64. PubMed ID: 10500500
[TBL] [Abstract][Full Text] [Related]
36. Recognition of platinum-induced DNA damage by nuclear proteins: screening for mechanisms.
Marples B; Adomat H; Billings PC; Farrell NP; Koch CJ; Skov KA
Anticancer Drug Des; 1994 Oct; 9(5):389-99. PubMed ID: 7945723
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, structure, and reactivity of monofunctional platinum(II) and palladium(II) complexes containing the sterically hindered ligand 6-(methylpyridin-2-yl)acetate.
Ma Y; Day CS; Bierbach U
J Inorg Biochem; 2005 Oct; 99(10):2013-23. PubMed ID: 16087242
[TBL] [Abstract][Full Text] [Related]
38. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.
Olaussen KA; Adam J; Vanhecke E; Vielh P; Pirker R; Friboulet L; Popper H; Robin A; Commo F; Thomale J; Kayitalire L; Filipits M; Le Chevalier T; André F; Brambilla E; Soria JC
Lung Cancer; 2013 May; 80(2):216-22. PubMed ID: 23410825
[TBL] [Abstract][Full Text] [Related]
39. Rates of intercalator-driven platination of DNA determined by a restriction enzyme cleavage inhibition assay.
Choudhury JR; Rao L; Bierbach U
J Biol Inorg Chem; 2011 Mar; 16(3):373-80. PubMed ID: 21086002
[TBL] [Abstract][Full Text] [Related]
40. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex.
Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V
Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]